🇺🇸 FDA
Pipeline program

VGX-6150

VGX-6150-01

Phase 1 mab completed

Quick answer

VGX-6150 for Hepatitis C, Chronic is a Phase 1 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Hepatitis C, Chronic
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials